Jump to main content

yr 〜
yr

Search results 4

Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy --

Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy --
Digital博士論文障害者向け資料あり
米田, 愛Sage Publications Ltd2019-12-04European Journal of Ophthalmology
National Diet Library
  • Subject HeadingAflibercept combination therapy photodynamic therapy polypoidal choroidal vasculopathy ranibizumab

Investigation of incidence and causes of acute vision loss during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration during a 4-year follow-up

Investigation of incidence and causes of acute vision loss during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration during a 4-year follow-up
Digital博士論文障害者向け資料あり
町田, 祥Wolters Kluwer Health, Inc.2023-03-20
National Diet Library
  • Subject Heading...) Intravitreal ranibizumab (IVR) Long-term follow-up Mac...

Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy

Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy
Digital博士論文
米田, 愛Sage Publications Ltd2019-12-04European Journal of Ophthalmology--p.---
Available onlineOther Libraries in Japan
  • Summary, etc....g intravitreal ranibizumab and photodynam......t intravitreal ranibizumab?photodynamic t......e intravitreal ranibizumab?photodynamic t......f intravitreal ranibizumab or intravitrea......e intravitreal ranibizumab?photodynamic t......e intravitreal ranibizumab?photodynamic therapy combinat...
  • Subject HeadingAflibercept combination therapy photodynamic therapy polypoidal choroidal vasculopathy ranibizumab

Investigation of incidence and causes of acute vision loss during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration during a 4-year follow-up

Investigation of incidence and causes of acute vision loss during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration during a 4-year follow-up
Digital博士論文
町田, 祥Wolters Kluwer Health, Inc.2023-03-20Retina
Available onlineOther Libraries in Japan
  • Subject Heading...) Intravitreal ranibizumab (IVR) Long-term follow-up Mac...

Reached to the end of result.

RSS